Prabhavathi Fernandes

Prabhavathi B. Fernandes was the founder of Cempra Pharmaceuticals, Inc., serving as President, Chief Executive Officer & Director since 2005.
Dr. Fernandes was the founder of Cempra, Inc., serving as President, Chief Executive Officer & Director since 2005.
Dr. Fernandes is the founder of Concord Biosciences LLC, serving as President, Chief Executive Officer & Director since 2000.
Dr. Fernandes is also the founder of DarPharma, Inc. Dr. Fernandes is currently Chairman of the National Preparedness & Response Science Board since 2018.
Dr. Fernandes is currently Chairman of the Global Antibiotic Research & Development Partnership since 2019.
Dr. Fernandes is currently an Independent Director at Aelin Therapeutics NV.
Dr. Fernandes is currently a Member of the Supervisory Board at.
Curetis GmbH.
Former positions include President, Chief Executive Officer & Director at Morphochem, Inc. from 1997 to 2010, Lead Independent Director at Ocugen, Inc. from 2020 to 2025, Independent Director at OpGen, Inc. from 2020 to 2024, Member at Empower AI, Inc., Principal at Squibb Corp., Senior Project Leader at Abbott Group Ltd. from 1983 to 1987, Principal at Temple University (Pennsylvania), Member at National Institutes of Health, Principal at The Fox Chase Cancer Center, Principal at Ghent University, Member of the Product Development Working Group at the National Institute of Allergy & Infectious Diseases from 2003 to 2004, and Independent Member-Supervisory Board at Curetis NV from 2016 to 2020.
Education includes a doctorate from Thomas Jefferson University, an undergraduate degree from the University of Bangalore, and a graduate degree from Christian Medical College.